SEGMENT REPORTING (Tables)

9 Months Ended

Sep. 30, 2016

Summarized financial information concerning the Company's reportable segments is shown in the following table (in thousands):



Three Months Ended September 30, 2015	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
Total revenue	$	20,983	$	7,051	$	28,034
Operating Income	697		1,445		2,142
Income before income taxes	782		1,429		2,211
Capital expenditures	228		812		1,040
Depreciation and amortization	988		178		1,166



Three Months Ended September 30, 2016	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
Total revenue	$	26,386	$	7,044	$	33,430
Operating Income	2,995		1,497		4,492
Income before income taxes	2,994		1,484		4,478
Capital expenditures	202		556		758
Depreciation and amortization	996		212		1,208



Nine Months Ended September 30, 2015	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
Total revenue	$	61,312	$	13,526	$	74,838
Operating Income	2,768		2,224		4,992
Income before income taxes	2,703		2,184		4,887
Capital expenditures	677		1,299		1,976
Depreciation and amortization	2,712		528		3,240



Nine Months Ended September 30, 2016	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
Total revenue	$	74,284	$	16,257	$	90,541
Operating Income	7,499		2,519		10,018
Income before income taxes	7,526		2,577		10,103
Capital expenditures	681		1,445		2,126
Depreciation and amortization	2,807		611		3,418

Revenue is attributed to individual countries based on customer location. Total revenue by principal geographic area was as follows (in thousands):



	Three Months Ended September 30,				Nine Months Ended September 30,
	2015		2016		2015		2016
United States	$	26,847	$	30,845	$	71,170	$	84,998
Europe	537		1,365		1,598		2,801
Other International	650		1,220		2,070		2,742
Total	$	28,034	$	33,430	$	74,838	$	90,541

Asset information by reportable segment as of December 31, 2015 is as follows (in thousands):



	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
Total assets	$	92,567	$	17,152	$	109,719
Net assets	48,175		15,353		63,528

Asset information by reportable segment as of September 30, 2016 is as follows (in thousands):



	Core Companion Animal Health		Other Vaccines, Pharmaceuticals and Products		Total
Total assets	$	104,363	$	19,949	$	124,312
Net assets	61,951		17,840		79,791

Total assets by principal geographic areas were as follows (in thousands):